NCT04943159View on ClinicalTrials.gov

Afamelanotide in Patients Suffering With Acne Vulgaris

PHASE2CompletedINTERVENTIONAL
Enrollment

3

Participants

Timeline

Start Date

August 24, 2010

Primary Completion Date

March 8, 2011

Study Completion Date

March 8, 2011

Conditions
Acne Vulgaris
Interventions
DRUG

Afamelanotide

Group A is administered afamelanotide implant on Days 0, 21 and 42; Group B is administered afamelanotide implant on Days 0 and 28.

Sponsors
All Listed Sponsors
lead

Clinuvel Pharmaceuticals Limited

INDUSTRY